Legal Representation
Attorney
Douglas R. Wolf
USPTO Deadlines
Next Deadline
96 days remaining
NOA E-Mailed - SOU Required
Due Date
March 28, 2026
Application History
46 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 12, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 11, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Sep 14, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Nov 10, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 15, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 23, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| May 23, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| May 23, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 23, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| May 23, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 21, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 20, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Mar 20, 2025 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Mar 20, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 12, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 12, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Aug 12, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 12, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 28, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 27, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Feb 27, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Feb 27, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 17, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 15, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 15, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 15, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 8, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| May 8, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 29, 2023 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Mar 28, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 31, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 31, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 11, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 23, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 26, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 26, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 26, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 26, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 26, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 26, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 20, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 4, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 3, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Feb 3, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 3, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 3, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Radiopharmaceutical compositions, namely, therapeutic radiopharmaceutical preparations for treating cancer; Radiopharmaceutical products, namely, diagnostic and therapeutic radiopharmaceutical preparations for cancer and infectious diseases; Radiopharmaceutical preparations for the treatment of cancer
Classification
International Classes
005